newsfilter
← Latest News
GlobeNewswire·

Evoke Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update

SOLANA BEACH, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders with an emphasis on GIMOTI®